| 08-Feb-10 05:34PM | Biotech ETFs Immune To Broad Selling Investor's Business Daily |
| 04-Feb-10 01:46PM | NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure EDGAR Online -5.61% |
| 03-Feb-10 06:02AM | NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financia EDGAR Online |
| 02-Feb-10 07:23PM | Nektar appoints Greer to board AP |
| 05:05PM | Nektar adds to board of directors at bizjournals.com |
| 04:15PM | Nektar Therapeutics Appoints R. Scott Greer to Board of Directors PR Newswire |
| 01-Feb-10 07:05PM | Symantec adds former Intuit CEO to board at bizjournals.com |
| 26-Jan-10 02:35PM | 3 Stocks Ready to Roar at Motley Fool |
| 02:31PM | Wall Street's Buy List at Motley Fool |
| 25-Jan-10 09:55AM | Earnings Surprises For Diagnostics Companies Creates Good Stock Price Entry Point For New Investors According To Industry Expert Wall Street Transcript |
| 19-Jan-10 08:22AM | InPlay: Nektar Therapeutics tgt raised to $15 at Brean Murray as recent data reduces risk in pegylating small molecule drugs Briefing.com |
| 13-Jan-10 05:08PM | Tech Showing Signs of Life Indie Research +13.51% |
| 10:36AM | Preliminary Data from Nektar Zacks.com |
| 12-Jan-10 09:47AM | UPDATE - Nektar posts prelim data from cancer trial at Reuters |
| 09:02AM | NEKTAR THERAPEUTICS Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 09:00AM | Nektar Therapeutics Announces Positive Topline Results for NKTR-102 From First Stage of Phase 2 Study in Platinum-Resistant Ovarian Cancer PR Newswire |
| 11-Jan-10 09:00AM | Jennerex Appoints Dr. Hoyoung Huh to Its Board of Directors PR Newswire |
| 06-Jan-10 07:05PM | Nektar names first chief science officer at bizjournals.com |
| 05:54PM | Nektar Therapeutics Names Stephen K. Doberstein, Ph.D. Senior Vice President and Chief Scientific Officer PR Newswire |
| 09:00AM | Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA PR Newswire |
| 22-Dec-09 02:21PM | Tomorrow's Monster Stock? at Motley Fool |
| 14-Dec-09 01:05PM | Nektar director resigns, another named at bizjournals.com |
| 08:30AM | NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financia EDGAR Online |
| 08:30AM | Dennis Winger Joins Nektar Therapeutics' Board of Directors PR Newswire |
| 30-Nov-09 06:05PM | Nektar names Masuoka chief medical officer at bizjournals.com |
| 05:28PM | NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 05:09PM | Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer PR Newswire |
| 13-Nov-09 03:48PM | Abbott: Brave or Stupid? at Motley Fool |
| 09:18AM | AstraZeneca Beats, Raises Zacks.com |
| 10-Nov-09 09:04AM | NEKTAR THERAPEUTICS Financials EDGAR Online Financials |
| 05-Nov-09 09:29AM | New Star Analyst Rankings for Nektar Therapeutics StarMine |
| 06:05AM | NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 04-Nov-09 05:00PM | Nektar Therapeutics Financial Results Call scheduled for 5:00 pm ET today CCBN |
| 04:43PM | NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online |
| 04:15PM | Nektar Therapeutics Reports Third Quarter 2009 Financial Results PR Newswire |
| 07:07AM | Q3 2009 Nektar Therapeutics Earnings Release - Time Not Supplied CCBN |
| 29-Oct-09 05:27PM | Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets PR Newswire |
| 28-Oct-09 06:40AM | Nektar Completes Enrollment Ahead of Schedule in Phase 2 Clinical Trial Evaluating NKTR-102 in Patients with Platinum-Resistant Ovarian Cancer PR Newswire |
| 27-Oct-09 12:35PM | Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego PR Newswire |
| 15-Oct-09 12:29PM | This Partnership Will Go No Further at Motley Fool |
| 14-Oct-09 01:19PM | Progenics: Investors Are Right To Be Wary at Seeking Alpha |
| 13-Oct-09 09:11AM | NEKTAR THERAPEUTICS Files SEC form 8-K, Regulation FD Disclosure EDGAR Online |
| 12-Oct-09 01:56PM | Nektar Presents Favorable Data Zacks.com |
| 10-Oct-09 07:00PM | Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix PR Newswire |
| 05-Oct-09 02:53PM | 5 Cold Stocks Heating Up at Motley Fool |
| 02-Oct-09 01:45PM | AstraZeneca: Nektar Deal to Add Value Zacks.com |
| 08:01AM | NEKTAR THERAPEUTICS Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob EDGAR Online |
| 23-Sep-09 01:38PM | [video] Bio-tech High Times at TheStreet.com |
| 22-Sep-09 03:25PM | Nektar Tastes Sweet at Motley Fool +9.40% |
| 02:46PM | AstraZeneca Tasting Nektar Zacks.com |
| 02:40PM | Nektar Therapeutics (NKTR) President and Chief Executive Officer to Ring The NASDAQ Stock Market Closing Bell GlobeNewswire |
| 02:29PM | Movers roundup: Rite Aid, Nektar Therapeutics AP |
| 10:50AM | Nektar climbs on trial data and partnership AP |
| 10:32AM | UPDATE - Nektar's cancer drug shows promise in early trial at Reuters |
| 08:52AM | Nektar Therapeutics upgraded by BMO Capital Markets Briefing.com |
| 08:00AM | NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress PR Newswire |
| 21-Sep-09 10:56PM | [$$] AstraZeneca Sets Licensing Deal With Nektar for Two Drugs at The Wall Street Journal Online +13.12% |
| 05:07PM | [$$] Stocks in the Spotlight Monday at Barron's Online |
| 01:02PM | Nektar could get up to $1.12B from AstraZeneca AP |
| 11:38AM | UPDATE - Nektar signs licensing deal with AstraZeneca, shares up at Reuters |
| 11:21AM | Dell Shares Slip After Multibillion-Dollar Buy at Forbes.com |
| 10:30AM | Dell Deals But Street Sags at Forbes.com |
| 08:46AM | UPDATE - Nektar signs licensing deal with AstraZeneca, shares up at Reuters |
| 07:50AM | Nektar to get up to $1.5 bln from AstraZeneca at MarketWatch |
| 07:30AM | UPDATE - Nektar signs licensing deal with AstraZeneca at Reuters |
| 07:00AM | Nektar Therapeutics to Host Conference Call to Discuss Today's Announcement of a New Partnership for NKTR-118 and NKTR-119 PR Newswire |
| 06:37AM | NEKTAR THERAPEUTICS Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure EDGAR Online |
| 06:00AM | AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation PR Newswire |
| 18-Sep-09 03:07PM | Nektar Therapeutics to Present at the UBS 2009 Global Life Sciences Conference in New York City PR Newswire |
| 13-Sep-09 07:00PM | Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118 PR Newswire |
| 31-Aug-09 04:13PM | Biotechs Not Showing Much Life at Barron's Online |
| 26-Aug-09 04:18PM | ICT Group, Novavax and Books-A-Million among 52-week highs SmallCapInvestor.com |
| 05-Aug-09 09:05AM | Nektar Therapeutics reports $32M loss in Q2 at bizjournals.com |
| 08:05AM | Nektar Therapeutics narrows Q2 loss to $32.1M at bizjournals.com |
| 06:04AM | NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 04-Aug-09 10:57PM | Nektar Therapeutics Q2 2009 Earnings Call Transcript at Seeking Alpha +5.57% |
| 05:00PM | Nektar Therapeutics Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:51PM | NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online |
| 04:15PM | Nektar Therapeutics Reports Second Quarter 2009 Financial Results PR Newswire |
| 02:40PM | MannKind 2Q loss narrows on lower expenses AP |
| 07:07AM | Q2 2009 Nektar Therapeutics Earnings Release - After Market Close CCBN |
| 31-Jul-09 03:48PM | Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City PR Newswire |
| 02:25PM | Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets PR Newswire |
| 27-Jul-09 12:31PM | [$$] Better Near-Term Biotech Picks at Barron's Online -5.36% |
| 08-Jul-09 08:00PM | Annual Report with 10K for Nektar Therapeutics WILink |
| 26-Jun-09 03:36PM | Rumors and Safety Issues -- One Bad Combination at Motley Fool |
| 02:04PM | Health Care Funds Get Obama Bounce at TheStreet.com |
| 19-Jun-09 01:24PM | MannKind Needs More Leaps at Motley Fool +7.28% |
| 11:05AM | Nektar shares rise on Morgan Joseph analyst view AP |
| 09-Jun-09 09:00AM | Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer PR Newswire |
| 01-Jun-09 03:14PM | 5-Star Stocks on the Upswing at Motley Fool |
| 01:53PM | BIOTECHNOLOGY STOCKS: EXPERTS PICK THE BEST Wall Street Transcript |
| 15-May-09 09:24AM | Fuqi International, Vanda Pharmaceuticals and Nektar Therapeutics lead small-cap volume in pre-market SmallCapInvestor.com |
| 14-May-09 03:57PM | UPDATE - UCB stock rises as U.S. clears arthritis drug at Reuters +22.33% |
| 03:39PM | Nektar shares rise as partner gets FDA approval AP |
| 01:28PM | Biotech Stocks: Drug stocks track broader market higher at MarketWatch |
| 12:47PM | Nektar Therapeutics, RXi Pharmaceuticals and Insight Enterprises lead small-cap percentage gainers SmallCapInvestor.com |
| 12:00PM | UPDATE - UCB soars as U.S. clears arthritis drug at Reuters |
| 09:46AM | Nektar Announces UCB's Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis PR Newswire |
| 12-May-09 04:15PM | Nektar Therapeutics to Present at the Deutsche Bank 34th Annual Health Care Conference in Boston PR Newswire |
